A method using strong anion exchange solid phase extraction (SAX-SPE) followed by liquid chromatography ultraviolet detection (LC-UV) for the analysis of flunixin in equine plasma for doping control in horse racing has been developed. By using SAX-SPE, commonly regulated non-steroidal anti-inflammatory drugs (NSAIDs) by the United States Equestrian Federation (USEF), i.e. PBZ, OPBZ, diclofenac, flunixin, ketoprofen, meclofenamic acid and naproxen, and an internal standard, i.e. flurbiprofen, were first selectively extracted. Then, baseline separation of flunixin from other NSAIDs, the internal standard, and residual components of equine plasma was achieved using LC-UV. Finally, flunixin in equine plasma was quantified after an internal calibration curve was created.
more »
« less
Quantification of phenylbutazone in equine plasma for doping control in horse racing using strong anion exchange solid phase extraction followed by liquid chromatography with UV detection
A method using strong anion exchange solid phase extraction (SAX-SPE) followed by liquid chromatography ultraviolet detection (LC-UV) for the analysis of phenylbutazone (PBZ) and its metabolite oxyphenbutazone (OPBZ) in equine plasma for doping control in horse racing has been developed. By using SAX-SPE, commonly regulated non-steroidal anti-inflammatory drugs (NSAIDs) by the United States Equestrian Federation (USEF), i.e. PBZ, OPBZ, diclofenac, flunixin, ketoprofen, meclofenamic acid and naproxen, and an internal standard, i.e. tolfenamic acid, were first selectively extracted. Then, baseline separation of PBZ, OPBZ from other NSAIDs, internal standard, and residual components of equine plasma was achieved using LC-UV. Finally, PBZ and OPBZ in equine plasma were quantified after an internal calibration curve was created.
more »
« less
- Award ID(s):
- 1827209
- NSF-PAR ID:
- 10173885
- Date Published:
- Journal Name:
- 111th Illinois State Academy of Science Annual Meeting
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
After attending this presentation, attendees will gain knowledge in the strategy to achieve high-throughput and simultaneous analysis of cannabinoids and appreciate a validated LC-UV method for analysis of twelve cannabinoids in hemp oil. This presentation will first impact the forensic science community by introducing three fast LC separations of twelve cannabinoids that can be used with either UV or mass spectrometric (MS) detection. It will further impact the forensic science community by introducing a validated LC-UV method for high-throughput and simultaneous analysis of twelve cannabinoids in hemp oil, which can be routinely used by cannabis testing labs. In recent years, the use of products of Cannabis sativa L. for medicinal purposes has been in a rapid growth, although their preparation procedure has not been clearly standardized and their quality has not been well regulated. To analyze the therapeutic components, i.e. cannabinoids, in products of Cannabis sativa L., LC-UV has been frequently used, because LC-UV is commonly available and usually appropriate for routine analysis by the cannabis growers and commercial suppliers. In the literature, a few validated LC-UV methods have been described. However, so far, all validated LC-UV methods only focused in the quantification of eleven or less cannabinoids. Therefore, a method able to simultaneously analyze more cannabinoids in a shorter run time is still in high demand, because more and more cannabinoids have been isolated and many of them have shown medicinal properties. In this study, the LC separation of twelve cannabinoids, including cannabichromene (CBC), cannabidiolic acid (CBDA), cannabidiol (CBD), cannabidivarinic acid (CBDVA), cannabidivarin (CBDV), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabinol (CBN), delta-8 tetrahydrocannabinol (Δ8-THC), delta-9 tetrahydrocannabinolic acid A (Δ9-THCA A), delta-9 tetrahydrocannabinol (Δ9-THC), and tetrahydrocannabivarin (THCV), has been systematically optimized using a Phenomenex Luna Omega 3 µm Polar C18 150 mm × 4.6 mm column with regard to the effects of the type of organic solvent, i.e. methanol and acetonitrile, the content of the organic solvent, and the pH of the mobile phase. The optimization has resulted in three LC conditions at 1.0 mL/minute able to separate the twelve cannabinoids: 1) a mobile phase consisting of water and methanol, both containing 0.1% formic acid (pH 2.69), with a gradient elution at 75% methanol for the first 3 minutes and then linearly increase to 100% methanol at 12.5 minutes; 2) a mobile phase consisting of water and 90% (v/v) acetonitrile in water, both containing 0.1% formic acid and 20 mM ammonium formate (pH 3.69), with an isocratic elution at 75% acetonitrile for 14 minutes; and 3) a mobile phase consisting of water and 90% (v/v) acetonitrile in water, both containing 0.03% formic acid and 20 mM ammonium formate (pH 4.20), with an isocratic elution at 75% acetonitrile for 14 minutes. In order to demonstrate the effectiveness of the achieved LC separations, a LC-UV method is further validated for the high-throughput and simultaneous analysis of twelve cannabinoids. The method used the mobile phase at pH 3.69, which resulted in significant improvement in throughput compared to other validated LC-UV methods published so far. The method used flurbiprofen as the internal standard. The linear calibration range of all the cannabinoids were between 0.1 to 25 ppm with R2≥0.9993. The LOQ (S/N=10) of the cannabinoids was between 17.8 and 74.2 ppb. The validation used a hemp oil containing 3.2 wt% CBD and no other cannabinoids, which was reported by the vendor with a certificate of analysis, as the matrix to prepare control samples: the hemp oil was first extracted using liquid-liquid extraction (LLE) with methanol; cannabinoids were then spiked into the extract at both 0.5 ppm and 5 ppm level. Afterwards, the recovery, precision (%RSD) and accuracy (%Error) of the control samples were assessed and the results met the requirements by the ISO/IEC 17025 and ASTM E2549-14 guidelines.more » « less
-
Bacterial–fungal interactions (BFIs) can shape the structure of microbial communities, but the small molecules mediating these BFIs are often understudied. We explored various optimization steps for our microbial culture and chemical extraction protocols for bacterial–fungal co-cultures, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that metabolomic profiles are mainly comprised of fungi derived features, indicating that fungi are the key contributors to small molecules in BFIs. LC-inductively coupled plasma MS (LC-ICP-MS) and MS/MS based dereplication using database searching revealed the presence of several known fungal specialized metabolites and structurally related analogues in these extracts, including siderophores such as desferrichrome, desferricoprogen, and palmitoylcoprogen. Among these analogues, a novel putative coprogen analogue possessing a terminal carboxylic acid motif was identified from Scopulariopsis sp. JB370, a common cheese rind fungus, and its structure was elucidated via MS/MS fragmentation. Based on these findings, filamentous fungal species appear to be capable of producing multiple siderophores with potentially different biological roles ( i.e. various affinities for different forms of iron). These findings highlight that fungal species are important contributors to microbiomes via their production of abundant specialized metabolites and that elucidating their role in complex communities should continue to be a priority.more » « less
-
more » « less
Abstract Nalbuphine was a semisynthetic opioid analgesic widely used in the treatment of both acute and chronic pain. We developed and validated a rapid, simple and sensitive method by ultra-performance liquid chromatography–tandem mass spectrometry (MS/MS) for the simultaneous quantitation of nalbuphine in human plasma, and we reported the pharmacokinetic features of patients during general anesthesia for abdominal surgery. Sample separation was achieved on a Kinetex Phenyl-Hexyl column (50 × 2.1 mm, 1.7 μm) after simple protein precipitation with acetonitrile. The mobile phase was composed of acetonitrile and 3 mM of ammonium acetate aqueous solution with 0.1% formic acid. Gradient elution was used in 4.5 min with a flow rate of 0.5 mL/min at 40°C. MS detection using AB Sciex QTRAP 5500 mass spectrometer was characterized by electrospray ionization for positive ions in multiple reaction monitoring mode. Quantitative ion pairs were m/z 358.4 → 340.1 for nalbuphine and m/z 340.0 → 268.3 for nalmefene, which were used as the internal standard (IS). The calibration curves showed good linearity (r2>0.99) over concentration range of 0.1–500 ng/mL. The intra-and inter-batch precisions were within 10.67%, and accuracy ranged from 94.07 to 105.34%. The IS–normalized matrix factors were 1.02–1.03 with RSD% (≤5.82%). The recoveries ranged from 101.09 to 106.30%. In conclusion, a rapid, simple, sensitive and economical analytical method was developed and validated to detect the concentration in plasma samples obtained from patients receiving nalbuphine intravenous injection and was successfully applicated to human pharmacokinetic studies of nalbuphine.
-
more » « less
Abstract Previously compound
12 showed great anti‐trypanosome activity without toxicity in anin vivo study. In the current study, a sensitive and rapid high‐performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) method was developed and validated to investigate its pharmacokinetics in mouse plasma. A protein precipitation method was applied to extract the compound, and it was then separated using a Kinetex C18column with mobile phase consisting of acetonitrile–0.1% formic acid water (50:50, v/v) at a flow rate of 300 μl/min. The analytes were detected with the multiple reaction monitoring in negative electrospray ionization source for quantitative response of the compounds. Compound12 was detected atm/z 477.0 → 367.2, while the internal standard compound14 was detected atm/z 499.2 → 268.2. Inter‐ and intra‐day precision was <5.22 and 2.79% respectively, while the accuracy range was within ±9.65%. The method was successfully applied to evaluate the pharmacokinetics of compound12 in mouse plasma with two formulations (20% Cremophor EL or sesame oil) and drug administration routes (oral and intraperitoneal injection). We observed a better drug serum concentration with the Cremophor formulation, and the two different drug administration routes did not show significant differences from the drug distribution.
- Free Publicly Accessible Full Text
-
Accepted Manuscript1.0
- Conference Paper:
- The DOI is not currently available.
